October 21, 2019

October 18, 2019

Subscribe to Latest Legal News and Analysis

Nouryon Launches Imagine Chemistry Collaborative Innovation Challenge

On January 8, 2019, Nouryon, a Biobased and Renewable Products Advocacy Group (BRAG®) member, announced the official launching of the Imagine Chemistry challenge. A program focused on startups, scale-ups, university spin-offs, and other newcomers in chemistry, the challenge aims to increase developing business’ opportunities to collaborate in the commercial adoption of green chemistry. In the 2019 edition of the challenge, Nouryon is seeking solutions to five areas:

  • Sustainable bio-based surfactants for everyone;
  • Label-free chemistries;
  • Sensing in demanding chemical environments;
  • Performance-boosting nanoparticles; and,
  • Pushing frontiers of chemical innovation.

Interested parties can submit their ideas online and receive expert feedback until March 8, 2019. In May 2019, 20 finalists will be selected for a three-day event at Nouryon’s research and development and innovation (RD&I) center in the Netherlands. These finalists will get an opportunity to work with experts and business leaders at the RD&I center to further develop their ideas into a joint value case.

©2019 Bergeson & Campbell, P.C.

TRENDING LEGAL ANALYSIS


About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Owner of Bergeson & Campbell, P.C. (B&C®), Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy...

202-557-3801